Carl Doershuk, M.D. - Publications

Affiliations: 
 

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1999 Smith AL, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Redding G, Rubio T, Williams-Warren J, Wilmott R, Wilson HD, Yogev R. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. The Journal of Pediatrics. 134: 413-21. PMID 10190914 DOI: 10.1016/S0022-3476(99)70197-6  0.301
1994 Konstan MW, Stern RC, Doershuk CF. Efficacy of the Flutter device for airway mucus clearance in patients with cystic fibrosis. The Journal of Pediatrics. 124: 689-93. PMID 8176554 DOI: 10.1016/S0022-3476(05)81356-3  0.306
1994 Cabrera ME, Lough MD, Doershuk CF, Salvator AE. An expanded scoring system including an index of nutritional status for patients with cystic fibrosis. Pediatric Pulmonology. 18: 199-205. PMID 7838617 DOI: 10.1002/Ppul.1950180402  0.323
1988 Smith AL, Redding G, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, Moss R, Ramsey B, Rubio T. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. The Journal of Pediatrics. 112: 547-54. PMID 3127569 DOI: 10.1016/S0022-3476(88)80165-3  0.338
1987 Tablan OC, Martone WJ, Doershuk CF, Stern RC, Thomassen MJ, Klinger JD, White JW, Carson LA, Jarvis WR. Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest. 91: 527-32. PMID 3829745 DOI: 10.1378/Chest.91.4.527  0.309
1986 Stern RC, Rothstein FC, Doershuk CF. Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition. 5: 35-40. PMID 3003321 DOI: 10.1097/00005176-198601000-00007  0.34
1985 Green CG, Doershuk CF, Stern RC. Symptomatic hypomagnesemia in cystic fibrosis. The Journal of Pediatrics. 107: 425-8. PMID 4032136 DOI: 10.1016/S0022-3476(85)80526-6  0.304
1982 Stern RC, Boat TF, Doershuk CF. Obstructive azoospermia as a diagnostic criterion for the cystic fibrosis syndrome. Lancet (London, England). 1: 1401-4. PMID 6123689  0.344
1981 Jacobstein MD, Hirschfeld SS, Winnie G, Doershuk C, Liebman J. Ventricular interdependence in severe cystic fibrosis. A two-dimensional echocardiographic study. Chest. 80: 399-404. PMID 7273891 DOI: 10.1378/Chest.80.4.399  0.358
1978 Stern RC, Boat TF, Abramowsky CR, Matthews LW, Wood RE, Doershuk CF. Intermediate-range sweat chloride concentration and Pseudomonas bronchitis. A cystic fibrosis variant with preservation of exocrine pancreatic function. Jama. 239: 2676-80. PMID 650841 DOI: 10.1001/Jama.1978.03280520048017  0.302
1978 Fink RJ, Doershuk CF, Tucker AS, Stern RC, Boat TF, Matthews LW. Pulmonary function and morbidity in 40 adult patients with cystic fibrosis. Chest. 74: 643-7. PMID 104832  0.329
1977 Stern RC, Boat TF, Doershuk CF, Tucker AS, Miller RB, Matthews LW. Cystic fibrosis diagnosed after age 13. Twenty-five teenage and adult patients including three asymptomatic men. Annals of Internal Medicine. 87: 188-91. PMID 889200  0.337
1977 Fink RJ, Doershuk CF, Boat TF. Course of the pulmonary involvement during adulthood in forty patients with cystic fibrosis (CF) American Review of Respiratory Disease. 115: II.  0.378
1976 Stern RC, Doershuk CF, Boat TF, Tucker AS, Primiano FP, Matthews LW. Course of cystic fibrosis in black patients. The Journal of Pediatrics. 89: 412-7. PMID 956965 DOI: 10.1016/S0022-3476(76)80538-0  0.375
1976 Stern RC, Boat TF, Doershuk CF, Tucker AS, Primiano FP, Matthews LW. Course of cystic fibrosis in 95 patients. The Journal of Pediatrics. 89: 406-11. PMID 956964 DOI: 10.1016/S0022-3476(76)80537-9  0.329
1973 Liebman J, Krause DA, Doershuk CF, Downs TD, Matthews LW. Orthogonal vectorcardiogram in cystic fibrosis. Diagnostic significance and correlation with pulmonary function tests; a four year follow-up. Chest. 63: 218-26. PMID 4265843  0.325
1968 MAKLEY JT, HERNDON CH, INKLEY S, DOERSHUK C, MATTHEWS LW, POST RH, LITTELL AS. Pulmonary Function in Paralytic and Non-Paralytic Scoliosis before and after Treatment The Journal of Bone & Joint Surgery. 50: 1379-1390. DOI: 10.2106/00004623-196850070-00007  0.372
1967 Matthews LW, Doershuk CF. Measurement of pulmonary function in cystic fibrosis. Bibliotheca Paediatrica. 86: 237-46. PMID 6054634  0.347
1967 Liebman J, Doershuk CF, Rapp C, Matthews L. The vectorcardiogram in cystic fibrosis. Diagnostic significance and correlation with pulmonary function tests. Circulation. 35: 552-69. PMID 6021336 DOI: 10.1161/01.Cir.35.3.552  0.309
1964 MATTHEWS LW, DOERSHUK CF, WISE M, EDDY G, NUDELMAN H, SPECTOR S. A THERAPEUTIC REGIMEN FOR PATIENTS WITH CYSTIC FIBROSIS. The Journal of Pediatrics. 65: 558-75. PMID 14216644  0.317
1964 Llebman J, Doershuk C, Rapp C, Matthews L. 79. The vectorcardiogram in patients with cystic fibrosis: Its relationship to functional status as evaluated by pulmonary function tests The American Journal of Cardiology. 13: 116-117. DOI: 10.1016/0002-9149(64)90309-1  0.392
1964 Doershuk CF, Tucker AS, Spector S, Matthews LW. Pulmonary function and clinicalevaluation of a prophylactic approach to therapy of cystic fibrosis The Journal of Pediatrics. 65: 1112-1114.  0.322
Show low-probability matches.